Trial Profile
Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- 19 Mar 2017 Status changed from recruiting to completed according to results presented at the 66th Annual Scientific Session of the American College of Cardiology.
- 04 Mar 2015 New trial record